International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Glycemic Targets.

Select Content Type
Clinical Guidelines
Authored By
de Bock M, Agwu JC, Deabreu M, Dovc K, Maahs DM, Marcovecchio ML, Mahmud FH, Nóvoa-Medina Y, Priyambada L, Smart CE, DiMeglio LA
Authored On
Interests
Endocrinology
Internal/Family Medicine
Pediatric Medicine
Speciality
Endocrinology
Internal/Family Medicine
Pediatric Medicine
Book Detail
volume
97
ISSN
1663-2826
No. of pages
9
Publication Date
Actions
Download in App
Promotional Categories
Featured
Event Data
{"article_title":"International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Glycemic Targets.","author":"\"de Bock, Martin , Agwu, Juliana Chizo , Deabreu, Matt , Dovc, Klemen , Maahs, David M , Marcovecchio, M Loredana , Mahmud, Farid H , N\u00f3voa-Medina, Yeray , Priyambada, Leena , Smart, Carmel E , DiMeglio, Linda A\"","journal_title":"Hormone research in paediatrics","issn":"1663-2826 ; Electronic","isbn":"","publication_date":"20240101","volume":"97","issue":"6","first_page":"546","page_count":"9","accession_number":"39701064","doi":"10.1159\/000543266","publisher":"Karger","doctype":"Journal Article; Practice Guideline","subjects":"Pediatrics","interest_area":["Endocrinology"," Pediatric Medicine"," Internal\/Family Medicine"],"abstract":"The International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines represent a rich repository that serves as the only comprehensive set of clinical recommendations for children, adolescents, and young adults living with diabetes worldwide. This chapter builds on the 2022 ISPAD guidelines, and updates recommendations on the glycemic targets for children and adolescents living with diabetes. A new target for hemoglobin A1c (HbA1c) of \u22646.5% (48 mmol\/mol) is recommended for those who have access to advanced diabetes technologies like continuous glucose monitoring and automated insulin delivery. This target should be encouraged for all children and adolescents living with diabetes when safely achievable. In other settings, the HbA1c target is \u22647.0% (53 mmol\/mol). The International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines represent a rich repository that serves as the only comprehensive set of clinical recommendations for children, adolescents, and young adults living with diabetes worldwide. This chapter builds on the 2022 ISPAD guidelines, and updates recommendations on the glycemic targets for children and adolescents living with diabetes. A new target for hemoglobin A1c (HbA1c) of \u22646.5% (48 mmol\/mol) is recommended for those who have access to advanced diabetes technologies like continuous glucose monitoring and automated insulin delivery. This target should be encouraged for all children and adolescents living with diabetes when safely achievable. In other settings, the HbA1c target is \u22647.0% (53 mmol\/mol).","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=39701064&authtype=shib&custid=ns346513","isPdfLink":true,"isSAML":false,"additionalInfo":{"Authored_By":"de Bock M, Agwu JC, Deabreu M, Dovc K, Maahs DM, Marcovecchio ML, Mahmud FH, N\u00f3voa-Medina Y, Priyambada L, Smart CE, DiMeglio LA","Journal_Info":"Publisher: Karger Country of Publication: Switzerland NLM ID: 101525157 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1663-2826 (Electronic) Linking ISSN: 16632818 NLM ISO Abbreviation: Horm Res Paediatr Subsets: MEDLINE","Publication_Type":"Journal Article; Practice Guideline","Published_Date":"2024-01-01","Source":"Hormone research in paediatrics [Horm Res Paediatr] 2024; Vol. 97 (6), pp. 546-554. Date of Electronic Publication: 2024 Dec 19.","Languages":"English","Electronic_ISSN":"1663-2826","MeSH_Terms":"Glycated Hemoglobin*\/metabolism , Glycated Hemoglobin*\/analysis , Blood Glucose*\/metabolism , Diabetes Mellitus, Type 1*\/blood , Diabetes Mellitus, Type 1*\/drug therapy , Glycemic Control*\/standards, Humans ; Adolescent ; Child ; Societies, Medical ; Female ; Male ; Blood Glucose Self-Monitoring ; Consensus","Subjects":"Humans, Adolescent, Child, Societies, Medical, Female, Male, Blood Glucose Self-Monitoring, Consensus, Glycated Hemoglobin metabolism, Glycated Hemoglobin analysis, Blood Glucose metabolism, Diabetes Mellitus, Type 1 blood, Diabetes Mellitus, Type 1 drug therapy, Glycemic Control standards","Title_Abbreviations":"Hormone research in paediatrics","Volume":"97"},"header":{"DbId":"mdl","DbLabel":"MEDLINE Ultimate","An":"39701064","RelevancyScore":"907","PubType":"Academic Journal","PubTypeId":"academicJournal","PreciseRelevancyScore":"906.541442871094"},"plink":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=39701064&authtype=shib&custid=ns346513&group=main&profile=eds","upload_link":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=39701064&authtype=shib&custid=ns346513&group=main&profile=eds"}
ISSN
1663-2826 ; Electronic
IS_Ebsco
true
Upload Link
https://search.ebscohost.com/login.aspx?direct=true&db=mdl&AN=39701064&authtype=shib&custid=ns346513
Additional Info
["de Bock M, Agwu JC, Deabreu M, Dovc K, Maahs DM, Marcovecchio ML, Mahmud FH, N\u00f3voa-Medina Y, Priyambada L, Smart CE, DiMeglio LA","Publisher: Karger Country of Publication: Switzerland NLM ID: 101525157 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1663-2826 (Electronic) Linking ISSN: 16632818 NLM ISO Abbreviation: Horm Res Paediatr Subsets: MEDLINE","Journal Article; Practice Guideline","2024-01-01","Hormone research in paediatrics [Horm Res Paediatr] 2024; Vol. 97 (6), pp. 546-554. Date of Electronic Publication: 2024 Dec 19.","English","1663-2826","Glycated Hemoglobin*\/metabolism , Glycated Hemoglobin*\/analysis , Blood Glucose*\/metabolism , Diabetes Mellitus, Type 1*\/blood , Diabetes Mellitus, Type 1*\/drug therapy , Glycemic Control*\/standards, Humans ; Adolescent ; Child ; Societies, Medical ; Female ; Male ; Blood Glucose Self-Monitoring ; Consensus","Humans, Adolescent, Child, Societies, Medical, Female, Male, Blood Glucose Self-Monitoring, Consensus, Glycated Hemoglobin metabolism, Glycated Hemoglobin analysis, Blood Glucose metabolism, Diabetes Mellitus, Type 1 blood, Diabetes Mellitus, Type 1 drug therapy, Glycemic Control standards","Hormone research in paediatrics","97"]
Description
The International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines represent a rich repository that serves as the only comprehensive set of clinical recommendations for children, adolescents, and young adults living with diabetes worldwide. This chapter builds on the 2022 ISPAD guidelines, and updates recommendations on the glycemic targets for children and adolescents living with diabetes. A new target for hemoglobin A1c (HbA1c) of ≤6.5% (48 mmol/mol) is recommended for those who have access to advanced diabetes technologies like continuous glucose monitoring and automated insulin delivery. This target should be encouraged for all children and adolescents living with diabetes when safely achievable. In other settings, the HbA1c target is ≤7.0% (53 mmol/mol). The International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines represent a rich repository that serves as the only comprehensive set of clinical recommendations for children, adolescents, and young adults living with diabetes worldwide. This chapter builds on the 2022 ISPAD guidelines, and updates recommendations on the glycemic targets for children and adolescents living with diabetes. A new target for hemoglobin A1c (HbA1c) of ≤6.5% (48 mmol/mol) is recommended for those who have access to advanced diabetes technologies like continuous glucose monitoring and automated insulin delivery. This target should be encouraged for all children and adolescents living with diabetes when safely achievable. In other settings, the HbA1c target is ≤7.0% (53 mmol/mol).<br /> (© 2024 The Author(s). Published by S. Karger AG, Basel.)
Published Date